Top Markets
#1 Akedo Akedo +128.53%
#2 TENDIES TENDIES +95.14%
#3 Threshold Network Threshold Network +43.87%
#4 Verus Coin Verus Coin +43.84%
#5 Mubarak Mubarak +28.64%
#6 Bitway Bitway +24.60%
#7 Palladium Network Palladium Network +22.70%
#8 Cash Cat Cash Cat +21.77%
#9 MultiversX MultiversX +18.70%
#10 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
Coin of the day
Akedo Akedo
설정
언어
한국어
통화
USD
테마
Regulus Therapeutics Inc. Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
주식 순위 #17600
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development... Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compound engineered to inhibit miR-21, which is currently in a Phase II clinical study for Alport syndrome, a severe renal condition. Another significant candidate, RGLS8429, an anti-miR agent targeting miR-17, is being evaluated in a Phase 1b clinical trial for autosomal dominant polycystic kidney disease. Beyond these clinical programs, Regulus is also cultivating an extensive preclinical portfolio, emphasizing drug candidates with precise, organ-selective delivery strategies. The company was established in 2007.
주가
$8.16
마지막 동기화: 2025-06-26
시가총액
$234.57M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Regulus Therapeutics Inc. (RGLS)

카테고리

Healthcare
Regulus Therapeutics Inc. (RGLS)의 P/B 비율
September 2026 기준 P/B 비율 TTM: 6.02
Regulus Therapeutics Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 6.02입니다. 2023년 말 기준 P/B 비율은 1.15였습니다.
Regulus Therapeutics Inc.의 P/B 비율 기록 (2010 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
2026 (TTM) 6.02 414.32%
2024 1.17 1.71%
2023 1.15 82.40%
2022 0.63 25.85%
2021 0.50 -72.50%
2020 1.81 136.39%
2019 0.77 -155.41%
2018 -1.39 -145.10%
2017 3.07 44.92%
2016 2.12 -41.35%
2015 3.61 -32.55%
2014 5.36 76.06%
2013 3.04 265.18%
2012 0.83 -3,304.62%
2011 -0.03 -119.29%
2010 0.13 0.00%
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.828 13.47%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.5116 24.83%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.2199 36.60%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9942 -33.62%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH